COMMITMENTS AND CONTINGENCIES (Details) $ in Thousands			1 Months Ended			3 Months Ended		9 Months Ended		12 Months Ended
	Dec. 27, 2023 USD ($)	Dec. 03, 2020 plaintiff	Jan. 31, 2024 claim	Dec. 31, 2023 claim	Sep. 30, 2022 claim	Sep. 30, 2024 USD ($) product	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) product	Sep. 30, 2023 USD ($)	Dec. 31, 2012 manufacturer	Mar. 04, 2024	Apr. 30, 2023
COMMITMENTS AND CONTINGENCIES
Lease term												5 years
Number of products marketed without approved NDAs or ANDAs | product						4		4
Total net revenues						$ 148,332	$ 131,829	$ 423,802	$ 355,162
Payment for acquired intangible assets								631	7,143
Number of plaintiffs | plaintiff		6
Number of potential manufacturers | manufacturer										7
Royalty percentage											5.00%
Net sales percentage											5.00%
Number of complaints filed | claim			1	200	2
Alvogen Inc | Product Intellectual Property
COMMITMENTS AND CONTINGENCIES
Payment for acquired intangible assets	$ 2,000
Novitium
COMMITMENTS AND CONTINGENCIES
Number of complaints filed | claim				29
Unapproved Products
COMMITMENTS AND CONTINGENCIES
Total net revenues						5,500	9,200	16,400	16,400
Unapproved Products | Contract Customer
COMMITMENTS AND CONTINGENCIES
Total net revenues						$ 100	$ 100	$ 100	$ 1,100